OIG Work Plan Continues to Prioritize Telehealth Fraud and Abuse Oversight

Introduction

The Office of Inspector General (OIG) for the Department of Health and Human Services (HHS) consistently outlines its strategic priorities through its annual Work Plan. This plan details the audits, evaluations, and investigations that the OIG intends to conduct across various HHS programs and operations. In recent years, particularly following the rapid expansion of telehealth services during the COVID-19 Public Health Emergency (PHE), telehealth has emerged as a significant area of focus for the OIG. The agency's ongoing scrutiny reflects a commitment to ensuring program integrity, preventing fraud, waste, and abuse, and promoting the efficient use of taxpayer dollars within Medicare and Medicaid.

Understanding the OIG Work Plan's Telehealth Focus

The OIG's Work Plan is a critical document for healthcare providers, as it signals areas of heightened enforcement risk. For telehealth, the OIG's objectives typically revolve around several key themes:

• Billing Compliance: Ensuring that telehealth services are billed correctly according to Medicare and Medicaid regulations, including appropriate coding, modifier usage, and place of service designations.
• Medical Necessity: Verifying that telehealth services provided were medically necessary and appropriate for the patient's condition, and that documentation supports this necessity.
• Service Delivery and Modalities: Assessing whether services delivered via telehealth were appropriate for the modality used (e.g., audio-only vs. audio-visual), and if the services were provided by an eligible practitioner to an eligible patient.
• Fraud Schemes: Identifying and investigating prevalent telehealth fraud schemes, such as those involving medically unnecessary durable medical equipment (DME), genetic testing, or prescription drugs ordered via telehealth.
• Program Integrity Risks: Evaluating the overall risks to program integrity posed by the expansion of telehealth, including potential for improper payments, lack of oversight, and patient harm.

Historical Context and Recent Trends

Prior to the PHE, telehealth utilization in Medicare was relatively limited. The PHE brought about significant waivers and flexibilities, dramatically increasing telehealth adoption. While many of these flexibilities have expired or been made permanent with adjustments, the OIG's commitment to oversight has not waned. Instead, it has intensified, shifting from an initial phase of assessing the impact of waivers to a more targeted approach of identifying vulnerabilities and prosecuting bad actors.

For example, the OIG's Work Plan for Fiscal Year (FY) 2024 continues to list several items related to telehealth. These include reviews of Medicare Part B telehealth services, particularly focusing on services provided during the PHE, and evaluations of state Medicaid programs' oversight of telehealth. The OIG has also expressed concerns about the potential for fraud related to remote patient monitoring and other digital health technologies.

Key Areas of OIG Scrutiny for Telehealth

1. Documentation of Medical Necessity: A recurring theme in OIG audits is the lack of adequate documentation to support the medical necessity of services. For telehealth, this means providers must clearly document why a telehealth visit was appropriate, the clinical rationale for the services rendered, and how the virtual encounter met the standard of care. This is especially crucial for services that could potentially be delivered in-person.

2. Billing and Coding Accuracy: The OIG examines whether providers are correctly using telehealth-specific CPT codes, modifiers (e.g., GT, 95, FQ), and place of service (POS) codes. Incorrect billing can lead to improper payments and recoupments. Providers must stay updated on the latest CMS guidance for telehealth billing, which has seen several changes post-PHE.

3. Patient-Provider Relationship and Licensure: The OIG scrutinizes whether a legitimate patient-provider relationship was established, particularly for new patients. Additionally, ensuring that the provider is appropriately licensed in the state where the patient is located at the time of service remains a critical compliance point, aligning with state medical board requirements.

4. Anti-Kickback Statute (AKS) and Stark Law Compliance: The OIG is vigilant about arrangements that could violate the AKS or Stark Law. This includes scrutinizing relationships between telehealth companies, marketing firms, laboratories, and pharmacies. Schemes involving the payment of kickbacks for patient referrals or ordering medically unnecessary services are high-priority targets.

5. Telehealth for Controlled Substances: While the DEA has its own set of rules regarding prescribing controlled substances via telehealth, the OIG also monitors for fraud related to such prescriptions, particularly in cases where the prescribing practices appear suspicious or lack a legitimate medical purpose.

Enforcement Actions and Trends

The OIG, often in conjunction with the Department of Justice (DOJ), has already brought significant enforcement actions against individuals and companies engaged in telehealth fraud. These cases often involve schemes where providers billed Medicare for medically unnecessary services, ordered unnecessary medical equipment or tests, or engaged in illegal kickback arrangements. The penalties can be severe, including criminal charges, civil monetary penalties, exclusion from federal healthcare programs, and recoupment of overpayments.

For example, the OIG's semiannual reports to Congress frequently highlight enforcement actions related to telehealth fraud, detailing millions of dollars in expected recoveries and numerous exclusions from federal healthcare programs. These actions serve as a stark reminder of the OIG's commitment to protecting the integrity of federal healthcare programs.

Conclusion

The OIG's consistent inclusion of telehealth oversight in its Work Plan underscores the enduring regulatory focus on this evolving area of healthcare delivery. Providers offering telehealth services, whether primarily to Medicare/Medicaid beneficiaries or commercial patients, must recognize that these OIG priorities set a benchmark for expected compliance. Proactive measures, including robust compliance programs, diligent documentation, accurate billing, and careful structuring of business arrangements, are essential to navigate this complex regulatory landscape and mitigate the risks of fraud and abuse. Staying informed about the OIG's ongoing work and CMS guidance is not merely advisable but critical for sustainable telehealth operations.

---

Source

• Source Name: Office of Inspector General (OIG), U.S. Department of Health and Human Services
• Source URL: https://oig.hhs.gov/reports-and-publications/workplan/index.asp
• Source Published At: October 2023 (for FY 2024 Work Plan, updated regularly)